Can a physician’s interpretation of a molecular pathology procedure (such as in the CPT® code range 81161–81408) be reported with CPT code 88291 (cytogenetics and molecular cytogenetics, interpretation and report)?
I am wondering if we should be charging for 82962 for hospital inpatients. All the documentation that we have found states it should not be used in a hospital setting.
In the answer to the June 12, 2017, laboratory question, you indicated that G0432, G0433, and G0435 should be used for a screening test for HIV infection. Isn’t code G0475 also used for this test?
What codes should be reported for testing blood platelets?
Does CMS permit a hospital to bill for lab services delivered to an ESRD patient?
What code(s) is reported for a screening test for HIV infection?
What codes can be assigned to report infectious agent molecular diagnostic testing using nucleic acid probes?
If lab services not related to ESRD are provided to patients in an ESRD facility, can the lab bill separately for them?
Does Medicare reimburse ESRD-related laboratory tests?
Can modifier 33 be used for laboratory claims?
Can I bill codes 83721 and 80061 together?
Does CMS allow modifier 91 with the NCCI PTP edits?
CPT® copyright 2024 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
